Stocks/ABUS

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

ABUS

↓ PDF (Pro)
Arbutus Biopharma Corporation Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$4.43
+0.61%today
MKT CAP
$871M
+2.3% · 1Y
Earnings History
-18.1%
+115.2%
-21.8%
+75.0%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$4.43
Low
$5.02
Analyst Mean
$5.24
High
$5.62
3 analystsNone
Full Financials
Trailing P/E-
Forward P/E-26.3x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+94.6%
5y Revenue CAGR-28.6%
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership20.5%
Institutional Ownership64.5%
Short % of Float13.47%
Days to Cover8.9d
1 Week+6.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
FilerRoleTypeSharesPriceValueDate
ANDROSKI LINDSAY J.D.Chief Executive OfficerStock28,000$0.00$0.00M2026-02-02
NGUYEN TUANChief Financial OfficerStock73,500$0.00$0.00M2026-02-02
NAFTZGER J CHRISTOPHERGeneral CounselStock54,300$0.00$0.00M2025-02-14
HASTINGS DAVID CChief Financial OfficerStock90,100$0.00$0.00M2025-02-14
SIMS KARENOfficerStock49,300$0.00$0.00M2025-02-14
Top Holders
HolderType% HeldValueΔ SharesAs of
Morgan Stanleyinstitution13.56%$0.12B+9.21%2025-12-31
Whitefort Capital Management, LPinstitution6.78%$0.06B+0.00%2025-12-31
Blackrock Inc.institution6.63%$0.06B+2.96%2025-12-31
Two Seas Capital Lpinstitution6.39%$0.06B+14.54%2025-12-31
Vanguard Group Incinstitution4.69%$0.04B+2.80%2025-12-31
State Street Corporationinstitution3.00%$0.03B+44.16%2025-12-31
Adar1 Capital Management, LLC institution2.75%$0.02B+86.52%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fundfund2.44%$0.02B+0.98%2025-12-31
Adage Capital Partners GP L.L.C.institution2.20%$0.02B-13.46%2025-12-31
Morgan Stanley Insight Fundfund2.00%$0.02B-4.00%2025-12-31
iShares Trust-iShares Russell 2000 ETFfund1.88%$0.02B+0.68%2026-03-31
Geode Capital Management, LLCinstitution1.87%$0.02B+0.30%2025-12-31
SPDR SERIES TRUST-State Street SPDR S&P Biotech ETFfund1.21%$0.01B+21.94%2026-03-31
Woodline Partners LPinstitution1.11%$0.01B+0.97%2025-12-31
MORGAN STANLEY INSTITUTIONAL FUND INC-Inception Portfoliofund1.09%$0.01B+2.36%2025-12-31
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fundfund0.84%$0.01B+4.23%2025-12-31
Fidelity Salem Street Trust-Fidelity Small Cap Index Fundfund0.75%$0.01B+1.13%2026-02-28
EQ Advisors Trust-EQ/Morgan Stanley Small Cap Growth Portfoliofund0.68%$0.01B-0.11%2025-12-31
iShares Trust-iShares Russell 2000 Growth ETFfund0.60%$0.01B-1.15%2026-03-31
iShares Trust-iShares Biotechnology ETFfund0.57%$0.00B-0.61%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Growth73Value58Quality82Momentum61Total5
Score breakdown on Starter+
Upgrade →
Score History (90d)
Pro onlyUpgrade →
Updated 5/8/2026
Recent Alerts
No alerts yet for ABUS.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.